Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir versus telbivudine in HBeAg-positive chronic hepatitis B with high viral load
ChiCTR-OCC-11001776Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of entecavir and telbivudine in Chronic Hepatitis B (CHB) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: HBV DNA, ALT and 1 more. Started Nov 2008; status: completed.
02
Drugs
entecavirtelbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OCC-11001776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCC-11001776.